KRAS and lung cancer: In conclusion, to the best of our knowledge, this is the first study to analyze the effects of c.309T>G in the MDM2 gene together with p53 Arg72Pro as well as mutations in the EGFR. KRAS and p53 genes on the prognoses of lung cancer patients.